Medtronic Launches MiniMed Go Smart MDI System in Europe
Event summary
- Medtronic launched the MiniMed Go Smart MDI system with Simplera sensor in Europe on February 25, 2026.
- The system integrates InPen smart insulin pen and Simplera sensor into a single mobile app.
- Real-world data shows users responding to missed dose alerts achieved 67.2% Time in Range.
- Pending CE mark approval for compatibility with Abbott's Instinct Go sensor.
The big picture
Medtronic's launch of the MiniMed Go Smart MDI system represents a strategic move to enhance diabetes management through advanced technology. The integration of real-time glucose monitoring and smart insulin dosing aims to address the critical challenge of missed insulin doses, which significantly impact glycemic control. This launch positions Medtronic to compete more effectively in the growing digital health market, particularly in Europe.
What we're watching
- Regulatory Approvals
- The pace at which CE mark approval for Abbott's Instinct Go sensor compatibility will be granted.
- Market Adoption
- Whether the system's real-time alerts and dose recommendations will significantly improve glycemic control outcomes.
- Competitive Positioning
- How Medtronic's integrated solution will differentiate against traditional and other connected insulin pens.